Fetal screening and whole genome sequencing: where are the limits?

Expert Rev Mol Diagn. 2021 May;21(5):433-435. doi: 10.1080/14737159.2021.1919087. Epub 2021 Apr 26.

Authors

Susan Hancock¹, Katherine Johansen Taber¹, James D Goldberg¹

Affiliation

¹ Department of Medical Affairs, Myriad Women's Health, South San Francisco, CA, USA.

PMID: 33866903
DOI: 10.1080/14737159.2021.1919087

No abstract available

Keywords: Noninvasive prenatal screening; carrier screening; cell-free DNA; noninvasive prenatal diagnosis; whole-genome sequencing.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Female
Humans
Pregnancy
Prenatal Diagnosis*
Whole Genome Sequencing